Nurse Practitioners advancing decentralised Hepatitis C care in opioid treatment

Hepatitis C virus (HCV) is a blood-borne virus linked to high morbidity and mortality. In Australia, 80% of cases result from unsterile injecting, making people who inject drugs a priority for HCV screening, testing, and treatment. Australia aims to eliminate HCV as a public health threat by 2030. A key strategy involves decentralizing HCV care and task-shifting to high-prevalence areas, such as alcohol and other drug services, including opioid pharmacotherapy and needle and syringe programs. This ensures care is accessible within the cultural contexts of priority populations, enhancing engagement in the HCV care cascade. Addiction nurse practitioners play a crucial role in expanding access to HCV treatment by leveraging existing therapeutic relationships with stigmatized groups. This presentation will highlight the AOD sector’s critical role in improving engagement in the HCV care cascade and improving patient outcomes.

Lucy Hanrahan | Nurse Practitioner Candidate, Gateway Health

Lucy Hanrahan is a registered nurse and nurse practitioner candidate specializing in opioid pharmacotherapy. With postgraduate studies in addiction and a master’s in nursing, she is dedicated to bridging healthcare gaps and enhancing holistic care for individuals with opioid use disorder. She is preparing to apply for nurse practitioner endorsement.

Sam Blake | Nurse Practitioner, Gateway Health

Sam Blake is an experienced addiction nurse practitioner who is passionate about opioid pharmacotherapy and ADHD treatment. With a strong commitment to improving patient outcomes, she integrates evidence-based practices and holistic approaches in her care. Sam is passionate about empowering patients and advocating for accessible, quality healthcare for all.

Credited Persons

The insert here Stream is Sponsored by